OTC Allergy Relief Medication Recalled for Failed Quality Specifications
L. Perrigo Company is recalling approximately 59,688 cartons of Fexofenadine Hydrochloride 180 mg allergy relief tablets nationwide because the product failed to meet FDA specifications for impurities and degradation.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II classification indicates potential for adverse health consequences, but no illnesses, injuries, hospitalization, or deaths have been reported. The hazard is a product quality issue without known harm to consumers, qualifying this as Moderate (2) rather than Severe (4).
Plain-English summary
L. Perrigo Company is recalling approximately 59,688 cartons of ALLERGY RELIEF Fexofenadine Hydrochloride 180 mg tablets distributed nationwide by Meijer Distribution, Inc. The product is available in three package sizes: 15-count (NDC 79481-0847-0), 30-count (NDC 79481-0847-1), and 45-count (NDC 79481-0847-2).
The recall was initiated because the product failed to meet FDA specifications for impurities and degradation. This is classified as an FDA Class II recall. Affected lot numbers and expiration dates are documented in the official recall notice.
Consumers who have purchased any of the affected lots should discontinue use and contact L. Perrigo Company or Meijer for instructions on return or refund. Any adverse effects experienced should be reported to the FDA's MedWatch program.
The recalled product
- Product
- ALLERGY RELIEF (FEXOFENADINE HYDROCHLORIDE)
- Brand
- ALLERGY RELIEF
- Manufacturer
- L. Perrigo Company
- Category
- Drug
- Hazard
- impurity
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (14)
- Lot #: a) 2JE1882
- Exp. date 01/24 b) 2FV1918
- 2ER0411
- Exp. date 01/24
- 2GV1902
- Exp. date 04/24
- 2CR0652
- 2DR0465
- Exp. date 12/23
- 2GR0329
- Exp. date 04/24 c)2CR0653
- 2DR0466
- 2ER0287
- 2ER0412
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · ALLERGY RELIEF
- HighAllergy Relief Fexofenadine Tablets Recalled for Failed Impurity Specifications
FDA (Drugs) · 2023-07-19
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27